An email containing the link(s) you need to access the Advance conference on Feb. 25 and Feb. 26 will be sent on the evening before each day of the program. Please check your inbox. 

For further questions contact or 1- 240-221-2900.

Expert Sessions Ramesh and Brenda Tripathi Vision Research Fund

Pre-registration is required to attend an Expert Session. Sign up during the conference registration process. If you are already registered for the conference, you can still add a session.


Meet the Experts

Thursday, Feb. 25
12:30 - 1:30pm EST

Breakout Room 1 - SOLD OUT

William MeilerWilliam F. Mieler, MD
Vice-Chairman, Department of Ophthalmology
Cless Family Professor of Ophthalmology
University of Illinois at Chicago

Applying to ophthalmology fellowship programs

William Mieler is the Cless Family Professor of Ophthalmology and vice-chairman for Education in the Department of Ophthalmology & Visual Sciences at the University of Illinois at Chicago (UIC), Chicago, Ill. He also serves as the director of Vitreoretinal Fellowship Training. Mieler received the UIC College of Medicine Faculty of the Year Award in 2016. His specialty areas include diseases and surgery of the retina and vitreous, along with ocular oncology.

Mieler is/has been the principal investigator or co-investigator of more than 60 scientific grants and collaborative studies. He has authored or co-authored 375 scientific papers, 91 book chapters, and eight textbooks, including The Retina Atlas, 2nd edition (2017) and Macular Surgery (2020). He has also presented 28 named lectures. Meiler has served on the editorial board of Archives of Ophthalmology, RETINA and Current Eye Research, and currently serves on the editorial board of The Asia Pacific Journal of Ophthalmology and the American Journal of Ophthalmology Case Reports. He also serves as a scientific reviewer for 40 additional scientific journals.

Mieler has served the American Board of Ophthalmology (ABO) as a Board director (1998-2005), chairman of the Board (2005), associate executive director (2006) and emeritus director (2006-present). He also served on several committees with the American Board of Medical Specialties (ABMS). Mieler is a past president of the Macula Society (2003-04) and has received the Gass Medal (2013). He has served on the Executive Committees of the Retina Society and the American Society of Retina Specialists (ASRS) and in 2011 was named recipient of the ASRS Founders Award. Mieler is a past member of the Pan-American Board of Directors (2001-08) and has chaired the PAAO Foundation Grants Committee (2006-11). From the American Academy of Ophthalmology (AAO), he has received the Honor Award (1992), the Lifelong Education for the Ophthalmologist Award (2000), the Senior Honor Award (2001) and the Life Achievement Honor Award (2011). He also has served as a member of the AAO Council (2001-08), the EyeNet Editorial Advisory Board (2003-07), and as chair of the Schepens Award (2007-10). He was a media spokesman for the AAO, a member and chair of the CME Advisory Task Force, a member of the Audit and Finance Committees and associate secretary for the AAO Subspecialty Day programs (2011-15). Mieler has also served on the ARVO Board of Trustees (2010-16) representing the Retina section, is a past ARVO president (2014-15) and has received the ARVO Distinguished Service Award (2016). Most recently, he was elected to serve on the AAO Board of Trustees (2017-20) and as a council member of the American Ophthalmological Society (2018-23). 

Breakout Room 2 - SOLD OUT

ME HartnettMary Elizabeth Hartnett, MD
Calvin S. and JeNeal N. Hatch Presidential Endowed Chair in Ophthalmology and Visual Sciences
Distinguished professor
University of Utah

Basic research in ophthalmology. Why? How?

Mary Elizabeth Hartnett holds the Calvin S. and JeNeal N. Hatch Presidential Endowed Chair in Ophthalmology and Visual Sciences and is a distinguished professor at the University of Utah. She is also an adjunct professor at the University of Utah departments of Neurobiology, Anatomy, and Pediatrics. Hartnett is the founder and director of Pediatric Retina at the John A. Moran Eye Center and principal investigator of the Retinal Angiogenesis Laboratory. She serves on the Scientific Advisory Board of the Jack McGovern Coats’ Disease Foundation.

As director of Moran's Pediatric Retina Center, Hartnett is one of a few pediatric retina specialists internationally trained to diagnose and treat pediatric retina disorders. She also practices as a vitreoretinal surgeon, providing treatment to patients throughout the Mountain West. Her mission is to deliver the best possible care and education while conducting critical research to make future advances in pediatric retina care.

Some of Hartnett’s accomplishments include creating the first-ever academic textbook on Pedatric Retina and serving as director of the Advances in Pediatric Retina meeting, held every two years. She has received numerous awards, including the Physician-Scientist Merit Award from Research to Prevent Blindness; the Honorary Lecture Award and Scientific Contribution Award from Women in Ophthalmology; the Macula Society's Paul Henkind Award and Arnall Patz Medal; the Association for Research in Vision and Ophthalmology's (ARVO) Weisenfeld Award; and the Paul Kayser/RRF Global Award.

Hartnett's prolific publication record includes more than 200 articles in peer-reviewed journals and 36 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, and as a mentor for the ARVO Leadership Development Program. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOneMolecular Vision, and the Journal of the American Association for Pediatric Ophthalmology and Strabismus.

Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of Association for Research in Vision and Ophthalmology (FARVO). She received her BS-MD from Rensselaer Polytechnic Institute and Albany Medical College, as part of a six-year biomedical program, and performed retinal fellowships in adult and pediatric retina at Schepens Retina Associates. She completed post-doctoral training at Harvard University/Schepens Eye Research Institute in retinal cell and molecular biology in the laboratory of Patricia D'Amore and then in GTPases and molecular cell biology at the University of North Carolina with Keith Burridge. Hartnett has served as retinal director for the residencies at State University of New York at Buffalo and Louisiana State University. 

Breakout Room 3 - SOLD OUT

Paul SternbergPaul Sternberg, Jr., MD, FARVO
Chair, ARVO Foundation Board of Governors
G. W. Hale Professor and Chair, Vanderbilt Eye Institute
Chief Medical Officer, Vanderbilt Medical Group
Chief Patient Experience Officer, Vanderbilt University Medical Center
Associate Dean for Clinical Affairs, School of Medicine

Building a successful career as a clinician-scientist

Paul Sternberg, Jr., is the G. W. Hale Professor and chair of the Department of Ophthalmology and Visual Sciences at the Vanderbilt Eye Institute, as well as chief medical officer and chief patient experience officer at Vanderbilt University Medical Center in Nashville, Tenn. He also serves as associate dean for clinical affairs at the Vanderbilt School of Medicine. Sternberg is a clinician-scientist specializing in retina with research studies targeting the pathogenesis of age-related macular degeneration. 

Breakout Room 4 - SOLD OUT

Adrienne GravesAdrienne Graves, PhD

Careers in industry

Adrienne Graves is a visual scientist by training and a global industry leader in ophthalmology. As the former CEO of Santen Inc., the U.S. subsidiary of a 130-year old Japanese pharmaceutical company, she successfully established a strong global presence, brought multiple ophthalmic products through development to approval and commercialization, and led global teams through successful acquisitions and partnerships. At Santen, Graves served as senior vice president of Worldwide Clinical Development (U.S., Europe and Japan) for seven years and CEO for eight years. Prior to Santen, she spent nine years at Alcon, joining as senior scientist to establish Alcon's first Retinal Electrophysiology Laboratory. She progressed through roles of increasing responsibility in R&D, including directing clinical development in multiple therapeutic areas and serving as director of International Ophthalmology. 

Graves currently serves as an independent director on the boards of Iveric Bio, Qlaris Bio, Nicox S.A., Surface Pharmaceuticals, Oxurion, TherOptix, and Greenbrook TMS. She previously held board positions at Encore Vision (2011 - 2017; acquired by Novartis), Envisia Therapeutics (2014 - 2017; assets acquired by Aerie Pharmaceuticals), TearLab Corporation (2005 - 2018), Aerpio Therapeutics (2012 - 2017), and Akorn (2012 - 2020). Graves also serves as a director on the following boards: American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation (Emeritus), Retina Global, Himalayan Cataract Project, Foundation Fighting Blindness (FFB) and the RD (Retinal Degeneration) Fund. She co-founded OWL (Ophthalmic World Leaders, formerly Ophthalmic Women Leaders) and Glaucoma 360, and is a Visionary Innovation Mentor at the Stanford University Ophthalmic Innovation Program. Her recent honors include the Visionary Award from Foundation Fighting Blindness, the Catalyst Award from Glaucoma Research Foundation, and the Visionary Award from OWL. Graves received an AB with Honors in psychology from Brown University, a PhD in psychobiology/neuroscience from the University of Michigan, and she completed a postdoctoral fellowship in visual neuroscience at the University of Paris. 

Breakout Room 5

Gillian McLellanGillian J. McLellan, BVMS, PhD, DVOphthal, DECVO, DACVO, MRCVS

Conducting research with animals is not what you think: Advocating for animals and science

Gill McLellan is a veterinary clinician-scientist who completed her veterinary degree, PhD and residency training in comparative ophthalmology in the U.K.  She currently holds a joint faculty position with tenure in both the School of Veterinary Medicine and the School of Medicine and Public Health at the University of Wisconsin-Madison.  Her main research interests are in comparative glaucoma and diseases of the optic nerve and retina.  She is current chair of the ARVO Animals in Research Committee and serves as ARVO’s Delegate to AAALAC International. 

Breakout Room 6 - SOLD OUT

Janet SerleJanet Serle, MD
Professor Emeritus of Ophthalmology
Icahn School of Medicine at Mount Sinai

Funding opportunities for young scientists

Janet B. Serle is professor emeritus of Ophthalmology at the Icahn School of Medicine at Mount Sinai. For over 20 years she was the director of both the Glaucoma Clinical and Glaucoma Research Fellowships at the Icahn School of Medicine at Mount Sinai. After graduation from Harvard Medical School, she completed a glaucoma research fellowship, a residency in ophthalmology and a glaucoma clinical fellowship at the Mount Sinai Medical Center, where she was a member of the full-time faculty from 1985 through 2018. Serle received a Senior Honor Award from the American Academy of Ophthalmology, has been principal investigator on more than 50 NIH- and industry-sponsored grants, and has published over 80 peer reviewed articles and chapters. Her research is focused on the medical and surgical management of glaucoma. She is past president of the New York Glaucoma Society, the NYC chapter of Women in Ophthalmology and also the New York Society for Clinical Ophthalmology. 

Breakout Room 7 - SOLD OUT

John S. PennJohn S. Penn, PhD
Phyllis G. and William B. Snyder, M.D., Endowed Professor and Vice Chairman, Ophthalmology and Visual Sciences
Associate Dean for Faculty Affairs
Vanderbilt University School of Medicine

Getting published: tips on writing a paper/Effective communication: tips for presenting and publishing

John S. Penn, received a PhD in molecular biophysics from Florida State University in 1984. He conducted fellowship training at the Cullen Eye Institute of Baylor College of Medicine for two years before joining the faculty there as an assistant professor in 1986. In 1989, Penn was recruited to the Jones Eye Institute at the University of Arkansas for Medical Sciences to become associate professor and founding director of the Arkansas Center for Eye Research. He joined the Vanderbilt University Department of Ophthalmology and Visual Sciences as professor, vice chairman and director of research in August 1998. At Vanderbilt, Penn also has appointments as professor in cell & developmental biology, molecular physiology & biophysics, pharmacology and neuroscience. In 2009, he was appointed associate dean for Faculty Affairs, Vanderbilt University School of Medicine.

Penn's research focuses on the molecular and cellular characterization of retinal vascular inflammation and angiogenesis with emphasis on biomarker identification and development of targeted therapies and novel mechanisms of drug delivery to the eye. He has been recognized for his contributions to eye research with the Dolly Green Scholars Award (1992), the Lew R. Wasserman Merit Award (1996) and the Research to Prevent Blindness Senior Scientific Investigator Award (2005). In 2006, he was awarded the William J. Darby Award for translational research. He has been continuously funded by the National Eye Institute of NIH since 1984 and currently holds three NEI R01 awards as principal investigator. Penn is a former ARVO Trustee (2009-2014) and president of the International Society for Eye Research (2016-2018). 

Breakout Room 8 - SOLD OUT

Mark GilliesMark Gillies, MBBS, PhD, FRANZCO
Clinical Ophthalmology and Eye Health
Central Clinical School
University of Sydney, Australia

Interaction with non-US Pharma

Mark Gillies is a clinician-scientist who is director of Research, Save Sight Institute, University of Sydney. The Macula Research Group's (MRG) Clinical Research Unit has conducted several major investigator-initiated randomized clinical trials, including the first on intravitreal injections for any ophthalmic disease. The MRG's Observational Studies Unit has developed internet-based software to track the outcomes of treatment of macular disease, the Fight Retinal Blindness! Project. His lab has interests in retinal metabolism, fibrosis and therapeutics. Gillies was a founder member and for many years chair of the Scientific Executive Committee of the MacTel Project. He has interacted extensively with the global offices of the major ophthalmic pharma companies. 

Breakout Room 9 - SOLD OUT

Jia YinJia Yin, MD, PhD, MPH
Harvard Medical School 
Mass Eye and Ear Infirmary

Juggling clinical responsibilities and science in the early years

Jia Yin is a clinician scientist at Harvard Medical School and Mass Eye and Ear Infirmary. Clinically, she specializes in corneal and external diseases, cataract surgery, corneal transplantation and refractive surgery. She conducts basic scientific and translational research in the areas of corneal angiogenesis, innervation and regeneration, with funding support from the NIH and Department of Defense. Her clinic research focuses on the diagnosis and treatment of corneal diseases, limbal stem cell deficiency, and other ocular surface diseases. 

Breakout Room 10 - SOLD OUT

Susmit Suvas

Susmit Suvas, PhD
Associate Professor, Department of Ophthalmology, Visual and Anatomical Sciences
Wayne State University School of Medicine

Practical advice for non-US trained vision scientists working in the U.S.

Susmit Suvas is an associate professor in the Department of Ophthalmology, Visual and Anatomical Sciences at Wayne State University School of Medicine. He received his PhD in cellular immunology from Institute of Microbial Technology (IMTech), a research Institute of the Council of Scientific and Industrial Research (CSIR), in INDIA. Suvas received his post-doctoral training in the area of ocular immunity and immunopathogenesis with Professor Barry Rouse at The University of Tennessee, Knoxville, Tenn.

Suvas has published highly-cited manuscripts on ocular viral infection and Foxp3 regulatory T cells. As an independent investigator, his lab focus is to understand and manipulate the pathways that promote chronic inflammation in HSV-1 infected corneas. He is specifically interested in understanding the interaction between peripheral nervous system and immune system, and immunometabolism during chronic inflammation. He has trained several PhD students and postdoctoral fellows and has received research funding from Midwest eye bank, Eversight, American Federation for aging research, and the National Eye Institute (NEI). 

 Breakout Room 11 - SOLD OUT

Pratap ChallaPratap Challa, MD, MS
Associate Professor of Ophthalmology
Director, Residency Training Program
Glaucoma Service
Duke University School of Medicine

The ins and outs of ophthalmology residency

Pratap Challa has been the residency program director for the Duke University Department of Ophthalmology since 2001. He has helped develop and administer the department's previous K12 program. In addition, he has served on resident, fellowship and medical student admission committees as well as the AAO's Resident Education Committee. Challa has also mentored numerous medical students, residents, graduate students and post-docs.

Breakout Room 12 - SOLD OUT

Lisa OstrinLisa Ostrin, OD, PhD
Associate Professor
University of Houston

Work life integration

Lisa Ostrin is currently an associate professor at the University of Houston College of Optometry. Following graduate school in Houston, Tex., she held post-doctoral positions at Johns Hopkins Wilmer Eye Institute and Berkeley Optometry School. She holds funding from the NEI. While moving from graduate school through post-doctoral positions and back to Houston as faculty, she and her husband, a physician researcher, have had four children. She is an advocate for work-life balance for young scientists.

Friday, Feb. 26, 2021
8 - 9am EST

Breakout Room 1 - SOLD OUT

Jacque DuncanJacque L. Duncan, MD
Department of Ophthalmology
University of California, San Francisco

Applying to ophthalmology residency programs

Jacque L. Duncan served on the Residency Selection Committee from 2005-2013, and served as the vice chair for medical student affairs in the Ophthalmology Department at UCSF from 2010-2017. She completed her internship and residency in ophthalmology at UCSF before going to the University of Pennsylvania to complete a fellowship in medical retina, specializing in inherited retinal degenerations and age-related macular degeneration. Duncan returned to UCSF to join the faculty in 2000. During and since that time, she has developed a retinal degenerations clinic at UCSF and initiated a research program in collaboration with Austin Roorda, PhD, at UC Berkeley School of Optometry, using high-resolution imaging techniques to study cone photoreceptor structure in the eyes of living patients with inherited retinal degenerations. 

Breakout Room 2 - SOLD OUT

Miller OgidigbenMiller Ogidigben
Medical Director - Retina
AbbVie US Medical Affair

Careers in Industry

Miller Ogidigben is a medical scientific executive with 20+ years of drug discovery/development experience, and strategic clinical trial tactical implementation at four Fortune 500 pharmaceutical companies. Ogidigben holds four patents in ophthalmology and directed two drug discoveries to clinical trials. Currently director within AbbVie Medical Affairs, he is responsible for establishing and maintaining professional relationships with key thought-leaders and providing medical director services including but not limited to clinical trials, medical and scientific research between industry, academic and clinical practice. Ogidigben has served as a member of the ARVO Science Pillar Steering Committee, chair of the Translational Science Working Group, and as an ARVO Developing Country Fellowship Program mentor. 

Breakout Room 3 - SOLD OUT

Demetrios VavvasDemetrios G. Vavvas, MD, PhD
Monte J. Wallace Ophthalmology Chair in Retina, Massachusetts Eye and Ear
Associate Professor of Ophthalmology, Harvard Medical School
Associate Director Retina Service Department of Ophthalmology
Co-Director, Ocular Regenerative Medicine Institute

Combining clinical practice, clinical research and basic science - can you do it all?

Demetrios G. Vavvas holds the Monte J. Wallace Ophthalmology Chair in Retina at Massachusetts Eye and Ear, is an associate professor of ophthalmology at Harvard Medical School, associate director of the Retina Service and co-director of the Ocular Regenerative Medicine Institute. A busy clinician and surgeon in the field of vitreoretinal diseases, he has performed a Phase I/II clinical trial of high dose statins as a potential to reverse high risk features in AMD.

Actively involved in education, Vavvas has served as chief resident and chief fellow at MEEI, receiving the Fellow of the Year Award for his teaching. He has graduated more than 70 clinical and research fellows and co-directs and organizes the Annual Fellows course tailored for first-year U.S. vitreoretinal fellows. He receives NIH funding and co-directs the Angiogenesis Laboratory studying neuroprotection and regulation of cellular energy status. He has also published more than 220 peer reviewed papers, holds several patents and has formed a small start-up company around the IP generated from his lab.

Breakout Room 4 - SOLD OUT

Arthur SitArthur J. Sit, SM, MD
Professor of Ophthalmology
Director, Glaucoma Fellowship
Department of Ophthalmology
Mayo Clinic, Rochester, MN

Getting published: tips on writing a paper/Effective communication: tips for presenting and publishing

Arthur J. Sit is a professor of ophthalmology and Glaucoma Fellowship director, Department of Ophthalmology at the Mayo Clinic in Rochester, Minn. Prior to medical school, he completed his bachelor’s degree in mechanical engineering at the University of Toronto, and a master’s degree in mechanical engineering at the Massachusetts Institute of Technology. He completed his medical school and residency at the University of Toronto and a glaucoma fellowship at the University of California San Diego.

His research interests focus on aqueous humor dynamics, the variations in intraocular pressure, ocular biomechanics, and novel technologies for the diagnosis and treatment of glaucoma. Recently, this has included the development of a novel device for the measurement of episcleral venous pressure and a novel device for in vivo assessment of ocular biomechanical properties. His work has been supported by the National Institutes of Health, the National Aeronautics and Space Administration (NASA), BrightFocus Foundation, Research to Prevent Blindness and industry grants.

Sit has been the recipient of the American Glaucoma Society Clinician-Scientist Award, the World Glaucoma Association Young Clinician Scientist Award and the American Academy of Ophthalmology Senior Achievement Award. He has been named to Best Doctors in America since 2009 and Who’s Who in America. He is co-chair of the Program Planning Committee for the World Glaucoma Congress and is a member of the Board of Governors for the World Glaucoma Association. He is past chair of the Research Committee for the American Glaucoma Society and is past president of the Minnesota Academy of Ophthalmology.

Breakout Room 5 - SOLD OUT

Julia BusikJulia Busik, PhD
Professor of Physiology
Michigan State University

How to make yourself visible - learning to self advocate

Julia Busik is professor of physiology at Michigan State University. She received her BS and MS degrees from Novosibirsk State University, USSR, and PhD from the Graduate University for Advanced Studies, Department of Physiology, Yokohama, Japan. Busik started research in the area of diabetic complications after joining Michigan State University as a post-doctoral fellow under the guidance of Douglas Henry. She has published over 70 papers in high-profile journals and is a well-recognized expert on the role of dyslipidemia in the development of diabetic complications. Busik has received the Carrier Development Award from the Juvenile Diabetes Research Foundation and numerous research awards from the National Eye Institute and American Diabetes Association, among other awards.

She was trained in the area of lipid metabolism by the leader of the field, Donald Jump. Realizing that limits in the sensitivity of available analytical methods prevented the development of lipidomic approach using limited retinal material, Busik started a collaboration with mass spectrometry expert Gavin Reid with the goal of developing a comprehensive lipidomic profiling approach to identify lipid pathways affected in diabetic retinopathy. This approach was successfully used to identify an important role of several lipid metabolic pathways in the retinas of diabetic animal model. Specifically, Busik and her colleagues determined that downregulation of retinal fatty acid elongation in diabetes leading to pro-inflammatory fatty acid profile changes with a decrease in the most abundant retinal n3 polyunsaturated fatty acid, docosahexaenoic acid (DHA). Moreover, they demonstrated dramatic upregulation of the central enzyme in sphingolipid metabolism, acid sphingomyelinase in the diabetic retina. Correction of diabetes-induced lipid profile changes with DHA supplementation dramatically inhibited activation of acid sphingomyelinase and vascular pathology in diabetic retina. Recently, Busik started collaboration with Denis Proshlyakov’s laboratory to determine the role of acid sphingomyelinase and increased ceramide production in mitochondrial damage in diabetic retina.  

Breakout Room 6 - SOLD OUT

Preeti SubramanianPreeti Subramanian, PhD
Director of Scientific Programs, Vision Science
BrightFocus Foundation

How to secure charitable funding

Currently, Preeti Subramanian is the director of scientific programs for vision science, overseeing the macular degeneration and glaucoma research programs at BrightFocus Foundation. Before joining BrightFocus, Subramanian was a research scientist at the National Eye Institute (NEI) of the NIH for 10+ years. She received her PhD in biochemistry from Virginia Commonwealth University in Richmond, Va., identifying a novel role for bioactive sphingolipid ceramide-1-phosphate (C1P) in mediating inflammation. She completed her post-doctoral training at the NEI, performing investigations on pigment epithelium-derived factor (PEDF), an ocular protein with neurotrophic activity. Subramanian continued her research in vision science at the NEI, identifying and studying potential therapeutic agents for diseases involving RPE oxidative stress (e.g., age-related macular degeneration). She has published more than 15 peer-reviewed articles in prestigious archival journals including Journal of Biological Chemistry and Investigative Ophthalmology of Visual Science

Breakout Room 7 - SOLD OUT

Paul BernsteinPaul S. Bernstein, MD, PhD
Val A. and Edith D. Green Presidential Professor of Ophthalmology and Visual Sciences
Moran Eye Center
University of Utah School of Medicine

How to secure NEI funding

Paul Bernstein joined the faculty of the University of Utah in 1995 where he currently divides his time equally between clinical and basic science retina research and a clinical practice devoted to medical and surgical treatment of disease of the retina and vitreous with special emphasis on macular and retinal degenerations. He is a recognized authority on nutritional biochemistry of the retina in AMD, fluorescence lifetime and Raman imaging of the retina, and the genetic and clinical characterization of MacTel. He currently serves as director of clinical research at the Moran Eye Center and was vice-president of ARVO from 2016-2017. 

Breakout Room 8 - SOLD OUT

Pedram HamrahPedram Hamrah, MD, FACS
Professor, Department of Ophthalmology, Neuroscience and Immunology
Adjunct Professor, Department of Bioengineering 
Director of Clinical Research
Director, Center for Translational Ocular Immunology
Cornea Service, New England Eye Center
Tufts Medical Center
Tufts University School of Medicine

Maximizing scientific achievement

Pedram Hamrah is a clinician-scientist and professor of ophthalmology at Tufts University School of Medicine, where he is director of clinical research and director of the Center for Translational Ocular Immunology. Hamrah’s research has been supported by numerous grants from the National Eye Institute, Research to Prevent Blindness, industry and foundation grants. He has authored over 140 peer-reviewed articles, over 40 reviews and book chapters, and has given more than 80 lectures and presentations worldwide. Hamrah currently serves as associate editor for the journals The Ocular SurfaceTranslational Vision, Science & Technology and BMC Ophthalmology; is Cornea Section editor of the journal Eye, and assistant editor of the journal Ocular Immunology and Inflammation

Breakout Room 9 - SOLD OUT

Jefferson DoyleJefferson Doyle, MD, PhD, MHS, MA(Oxon)
Assistant Professor in Ophthalmology (Division of Pediatrics) and Genetics
Wilmer Eye Institute
Johns Hopkins University School of Medicine

Practical advice for non-U.S. trained clinicians working in the U.S.

Jefferson Doyle completed medical school at Oxford and Cambridge (U.K.) and a PhD in genetics at Johns Hopkins. He completed residency at the Wilmer Eye Institute, Johns Hopkins, followed by fellowship in pediatric ophthalmology at Boston Children's Hospital, Harvard Medical School. He returned to Wilmer as assistant chief of Service and joined the full-time faculty as an assistant professor of ophthalmology in the Division of Pediatric Ophthalmology. He has a joint appointment in Genetics, is currently co-director of the Wilmer Genetic Eye Disease Center, and runs a translational research lab evaluating novel therapeutic strategies for genetic forms of pathological myopia. 

Breakout Room 10 - SOLD OUT

Ann LoganAnn Logan, PhD

Running a successful research lab

Ann Logan received her BSc from the University of London in 1974 and her PhD training in neuroendocrinology at the University of Birmingham between 1975 and 1978.  After post-doctoral training at the University of Leeds and in the laboratories of Professor Roger Guillemin and Professor Andrew Baird at Scripps Hospital, La Jolla, Calif., she established the Neurotrauma Research Group at the University of Birmingham in 1990, where she was professor of molecular neuroscience and head of the Neurotrauma Research Group within the College of Medicine and Dentistry until her retirement in March 2020. 

Logan's research interests centre upon regenerative biology with a particular interest in neurodegenerative conditions, with  particular focus on retinal diseases. Her work has generated more than 205 research publications on the roles, mechanisms, and exploitation of growth factor related compounds in diseased and damaged tissues. She strives to translate scientific advancements into the clinical arena for patient benefit. For example, through positions as head of neuroscience and ophthalmology, research theme lead for regenerative medicine in the Surgical Reconstruction and Microbiology Research Centre, and head of the Centre for Trauma Sciences Research while at the University of Birmingham, she delivered a number of key projects through to clinical trial and commercial exploitation. Since retirement Logan has continued to work with a number of industrial and academic partners on the development of functionalised biomaterials for ocular dressings, as well as supporting the translation of novel drugs and drug delivery technologies into the clinic. Her appointment in 2020 as Honorary Professor of Regenerative Biology at the University of Warwick facilitates her ongoing research with industrial and academic collaborators.

 Breakout Room 11 - SOLD OUT

Dimitra SkondraDimitra Skondra, MD, PhD
Associate Professor of Ophthalmology
Director, J. Terry Ernest Ocular Imaging Center
University of Chicago

Taking charge of advancing your career

Dimitra Skondra is an associate professor of ophthalmology at the University of Chicago and the director of the J. Terry Ernest Ocular Imaging Center. She is a highly respected, board-certified retina specialist, with a particular focus on the medical and surgical treatment of vitreoretinal diseases and advanced training and expertise in surgical repair of complex diabetic retinal detachments.

In addition to her clinical expertise, Skondra is an active researcher. As a physician-scientist, she is currently engaged in clinical and translational research in age-related macular degeneration, diabetes and other retinal diseases. She has established and is leading the Retina Microbiome Team in University of Chicago, a unique multidisciplinary team focusing on the role of gut microbiome in retinal diseases using specialized gnotobiotic animal models combined with clinical microbiome studies. She is a member of the Macula Society, Retina Society, American Society of Retina Specialists, European Vision Eye Research Society, American Academy of Ophthalmology, ARVO and Vitreous Buckle Society and has been the Ophthalmology Group Leader of Society of Immunotherapy for Cancer since 2017.

Throughout her career, Skondra has received several prestigious awards, including the ARVO Foundation Genentech Translational AMD award, University of Chicago OVS innovation Award, Retina Society Raymond Margherio Award, Harvard /Alcon Clinical Scholar Award, AUPO Research Award, ARVO/Alcon Early Career Clinician Scientist Award, Joslin-Tonseth Research Fellowship Award and the Knights Templar Award.

Breakout Room 12 - SOLD OUT

Barbara WirostkoBarbara Wirostko, MD, FARVO
Clinical Adjunct Professor
Department of Ophthalmology and Visual Sciences, University of Utah, Moran Eye Center, SLC
Adjunct Professor Department of Bioengineering, University of Utah, Salt Lake City, UT

Transition to being the mentor/sponsor for trainees

Barbara M. Wirostko is a doctor of ophthalmology, fellow of the American Academy of Ophthalmology, fellow of Association for Research in Vision and Ophthalmology, and has an active clinical research practice at the John A. Moran Eye Center, University of Utah as adjunct professor in the  Department of Ophthalmology and Visual Sciences and Department of Bio Engineering, University of Utah, SLC. As a serial entrepreneur, she currently serves as the chief medical officer (CMO) and co-founder of Qlaris Bio. Wirostko is a board-certified practicing glaucoma specialist and a clinician scientist. She was formally the CMO of EyeGate Pharmaceuticals, following its acquisition of Jade Therapeutics where she was co-founder and CSO, spearheading clinical development of its unique hyaluronic acid, Ocular Bandage Gel (OBG), for human use. For Jade Therapeutics, Wirostko, as PI, received $3M in SBIR funding for the OBG polymer from the DOD and NSF. In 2006 to 2010, she held leadership positions at Pfizer, N.Y., in ophthalmology, overseeing global medical responsibilities for the Xalatan franchise as senior medical director.

Wirostko sits on various editorial boards, including Ophthalmology Glaucoma, Acta Ophthalmologica and Journal of Glaucoma. She has published hundreds of peer-reviewed papers and books, serves on numerous advisory boards and grant review committees, and is the Moran Resident Research Director. She lectures globally on her area of clinical research expertise, exfoliation glaucoma. Wirostko received her MD from and completed her residency at Columbia University, College of Physicians and Surgeons, N.Y., and holds a BA with distinction in microbiology from Cornell University. She was awarded a fellowship at The New York Hospital Cornell Medical Center in glaucoma. She lives in Park City, Utah with her husband and children and leads a nationally recognized nonprofit in memory of their son, Joseph James Morelli, to award scholarships to high school and college with dyslexia pursing a STEM career.


Conference Program

View the Advance Conference program


Meet the Advance Conference keynote speakers Shawn Kanungo and Adrienne Scott, MD

Planning Committee

Meet the organizers of the Advance Conference